News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
Biotech/Pharma - Events
New Analyses Of Phase 2 Study Presented At ASBMR Show Romosozumab Treatment Resulted In Continued Increases In Bone Mineral Density 9/16/2014
Amgen (AMGN) Presents Analyses Of Phase 3 Ivabradine Data For The Treatment Of Chronic Heart Failure 9/15/2014
RedHill Biopharma Ltd. (RDHL) To Present At The 7th Annual Biopharm America International Partnering Conference 9/15/2014
Heart Failure Society Of America's 18th Annual Scientific Meeting To Focus On New Developments In Heart Failure Cause, Care And Treatment 9/15/2014
Northwest Biotherapeutics (NWBO) CEO To Present At SMI's 3rd Annual Cancer Vaccines Conference In London 9/15/2014
TiGenix To Participate Or Present At Key Conferences In The Second Half Of 2014 9/15/2014
Transgenomic, Inc. (TBIO) To Present At Fifth Annual Craig-Hallum Alpha Select Conference 9/15/2014
RestorGenex To Present At The American Association for Cancer Research Conference On Targeting The PI3K-MTOR Network In Cancer 9/15/2014
Drawbridge Pharmaceuticals To Present Clinical Findings Of Phaxan™ At Anesthesiology™ 2014 9/15/2014
Dolomite To Launch Meros TCU-100 Temperature Controller At Lab-On-A-Chip & Microarray World Congress 9/15/2014
Akebia Therapeutics, Inc. (AKBA) To Ring The NASDAQ Stock Market Opening Bell 9/12/2014
Radius (RDUS) To Present At The Biocentury Newsmakers In The Biotech Industry Conference 9/12/2014
Tute Genomics Launches MyGene Portal For Genome-Guided Medicine 9/12/2014
Champions Oncology, Inc. (CSBR) Reports Results For The First Quarter Ended July 31, 2014 9/12/2014
UIW Medical School Impacting San Antonio In A Big Way 9/12/2014
Biotechnology Industry Organization (BIO) Announces Plenary Sessions And Participants For The 2014 BIO Investor Forum 9/12/2014
Marrone Bio Innovations To Webcast Its Presentation At The Credit Suisse Basic Materials Conference 9/12/2014
Scancell To Present At Upcoming Scientific Conferences 9/12/2014
Novavax, Inc. (NVAX) To Host 2nd Annual Analyst And Investor Meeting 9/12/2014
VG Life Sciences, Inc. (VGLS)' Advisor Gives Preeclampsia Presentation At American Heart Association Conference 9/12/2014
Veeva Systems, Inc. To Host Analyst Day On Sept. 17, 2014 9/12/2014
ZS Pharma (ZSPH) To Present Data From Phase 3 Trial Of ZS-9 In Late-Breaking Session At Heart Failure Society Of America 18th Annual Scientific Meeting 9/11/2014
Amarantus BioSciences, Inc. To Present Orphan Ocular Data At Targeting Ocular Disorders Conference 2014 9/11/2014
Regenerative Medicine Foundation (RMF) Is New Organizer Of 2014 World Stem Cell Summit #WSCS14 In San Antonio, TX. 9/11/2014
Resolutions Adopted At Extraordinary General Meeting Of Shareholders Of Recipharm AB 9/11/2014
Scilex Pharmaceuticals To Present At Aegis Capital Healthcare & Technology Conference 9/11/2014
Orexigen Therapeutics, Inc. (OREX) To Host Conference Call And Webcast At 8:30 AM Eastern Time September 11, 2014 9/11/2014
Synthetic Biologics, Inc. (SYN) To Host Phase 2 Trimesta™ For Multiple Sclerosis Conference Call 9/11/2014
Biotechnology Industry Organization (BIO) Highlights The Value Of Intellectual Property For Animal Biotechnology At The 2014 Livestock Biotech Summit 9/11/2014
Fibrocell Science, Inc. Hosting R&D Day On September 24, 2014 9/11/2014
Institute of Human Virology Hosts Prominent AIDS Researchers During 16th Annual International Meeting 9/11/2014
Bristol-Myers Squibb Company (BMY) To Present At Bank Of America Merrill Lynch Global Health Care Conference 9/11/2014
AZBio Release: Life Science Innovators From Across The Rocky Mountain Southwest To Present At The White Hat Life Science Investor Conference In Phoenix On Sept. 17 & 18, 2014 9/11/2014
George Church And Feng Zhang To Keynote Inaugural Genome Editing Applications Conference 9/11/2014
Skyepharma PLC (SKYEF) To Present At Innovation In Respiratory Diseases Event 9/11/2014
CIVCO Unveils New Innovation Suite Showcasing The Broadest Portfolio Of Patient Positioning And Immobilization Solutions At ASTRO 2014 9/11/2014
Bristol-Myers Squibb Company (BMY) To Present At Bank of America (BAC) Merrill Lynch Global Health Care Conference 9/11/2014
Institute of Human Virology Hosts Prominent AIDS Researchers During 16th Annual International Meeting 9/11/2014
Pluristem Therapeutics (PSTI) To Deliver Scientific Presentations At 3rd International Placenta Stem Cell Society Meeting 9/10/2014
Cesca Therapeutics To Present At Aegis Healthcare & Technology Conference 9/10/2014
Cyclacel Pharmaceuticals, Inc. (CYCC) Announces Abstract Selected For Presentation At Society Of Hematologic Oncology Annual Meeting 9/10/2014
Galectin Therapeutics To Present At Aegis Capital Corporation 2014 Healthcare And Technology Conference 9/10/2014
BioMarin Pharmaceutical Inc. (BMRN) To Attend Upcoming Investor Conferences In London 9/10/2014
Receptos (RCPT) Announces Oral Podium Presentation At MS Boston 2014 9/10/2014
Heptares To Present At CNS Partnering & Deal-Making And Biopharm America 9/10/2014
Uroplasty, Inc. (UPI) To Participate In The 5th Annual Craig-Hallum Alpha Select Conference 9/10/2014
Mirati Therapeutics  (MRTX) To Present At BioCentury's NewsMakers In The Biotech Industry Conference 9/10/2014
Elekta Introduces Information-Guided Cancer Care, Highlighting Knowledge Management, At ASTRO 2014 9/10/2014
Amgen (AMGN) Announces 23 Abstracts To Be Presented At The American Society for Bone and Mineral Research 2014 Annual Meeting 9/10/2014
The Epilepsy Foundation Of Metropolitan New York To Host 3rd Annual Into The Light Walk For Epilepsy Awareness 9/10/2014
BioXcel To Present At The 2014 Aegis Capital Healthcare & Technology Conference 9/10/2014
Pressure BioSciences, Inc. (BBII) To Present At Rodman & Renshaw And Seethruequity NY Investment Conferences 9/10/2014
Genedata AG Screener For High Content Screening At Inaugural SBI2 Conference 9/10/2014
SynteractHCR Presenting And Exhibiting At Three Biopharma And Life Sciences Events This Fall 9/10/2014
Acorda Therapeutics (ACOR) And HealthCore To Present Real World Health Economics And Outcomes Data On Multiple Sclerosis Therapy AMPYRA 9/10/2014
Ansun Biopharma Announces Late Breaker Oral Presentation At ICAAC On The Clinical Activity Of Paradase™, An Investigational Drug For The Treatment Of Severe Parainfluenza Infection 9/10/2014
Diabetes: Boehringer Ingelheim Corporation And Eli Lilly and Company (LLY) Announce Data On Portfolio To Be Presented At The 50th EASD Annual Meeting 9/9/2014
Data On GlycoMimetics, Inc. (GLYC)' Drug Candidate's Potential To Treat Lung Infections Caused By Pseudomonas Aeruginosa To Be Presented At North American Cystic Fibrosis Conference 9/9/2014
SELLAS Life Sciences Group To Present At The Annual AEGIS Healthcare & Technology Conference 9/9/2014
Scioderm To Present Data From Phase 2b Study Of Zorblisa™ (SD-101) At The Debra International Congress 9/9/2014
Eli Lilly and Company (LLY) Highlights Latest Work In Diabetes Discovery And Development At 2014 European Association For The Study Of Diabetes Annual Meeting 9/9/2014
Karyopharm Therapeutics (KPTI) Announces Three Clinical Data Presentations At ESMO 2014 9/9/2014
NeoStem, Inc. And PCT, A Neostem Company, To Present At Multiple September Conferences 9/9/2014
Apollo Medical Holdings To Present At The Aegis Capital Corporation 2014 Healthcare & Technology Conference 9/9/2014
ACTRIMS Release: The World's Largest Conference Focused On Multiple Sclerosis Opens This Week In Boston, Massachusetts With Over 8,000 Participants Attending From Around The World 9/9/2014
Blueprint Medicines To Participate In Morgan Stanley (MST) Global Healthcare Conference 2014 9/9/2014
Durata Therapeutics, Inc.  (DRTX) Presented Data At The 54th Interscience Conference On Antimicrobial Agents And Chemotherapy (ICAAC) 9/9/2014
Ohr Pharmaceutical (OHRP) Announces Squalamine Eye Drop (OHR-102) Clinical Data Presentations At The Retina Society 47th Annual Scientific Meeting 9/9/2014
Verona Pharma (VRP.L) Release: RPL554 Presentations At ERS Congress Highlight Its Valuable Potential In Combination Therapy For COPD And Other Respiratory Diseases 9/9/2014
LakePharma Hosts Its Second Annual Antibody Engineering Symposium 9/9/2014
SuppreMol's Clinical Data In SLE For Its Lead Product SM101 Accepted For Presentation At The 2014 ACR / ARHP Annual Meeting In Boston 9/9/2014
BioPharm America™ 2014 Leads Off With Fierce 15 Announcement And Keynote Address Featuring Chief Scientific Officer From Sanofi (France) (SAN.PA) 9/9/2014
Sciformix To Present New Change Management Model For Regulatory Operations Outsourcing At DIA EDM 2014 9/9/2014
Exelixis, Inc. (EXEL) To Present At The Morgan Stanley Global Healthcare Conference On Tuesday, September 9 9/9/2014
Incyte Corporation (INCY) To Present At The 21st Annual Biocentury NewsMakers Conference 9/9/2014
BioTime (BTX) CEO Dr. Michael D. West To Present At Rodman & Renshaw 16th Annual Healthcare Conference 9/9/2014
Massachusetts General Hospital Release: 2014 Chabner Colloquium Focuses On Collaboration In Cancer Trials 9/9/2014
AxoGen, Inc. (AXGN) To Host Surgeon Panel On Nerve Repair At American Association Of Oral and Maxillofacial Surgeons Annual Meeting 2014 9/9/2014
Merck & Co., Inc. (MRK) To Participate At The Morgan Stanley Global Healthcare Conference 9/9/2014
ProSensa Holding N.V. (RNA) Announces 12 Presentations At The 19th International Congress Of The World Muscle Society In Berlin 9/9/2014
Varian Medical Systems (VAR)' ASTRO Exhibit Spotlights Technology And Software That Support Knowledge Sharing Among Oncology Professionals 9/9/2014
NanoViricides, Inc. (NNVC.PK) Reports That It Has Designed And Commenced Synthesis Of Novel Ebola Drug Candidates; Dr. Seymour To Present At Rodman & Renshaw Conference In New York Today 9/9/2014
Trevi Therapeutics Selected To Exhibit Poster At 2014 Annual Meeting of the American College of Clinical Pharmacology 9/9/2014
TG Therapeutics, Inc. (MHA) To Present At The 16th Annual Rodman & Renshaw Global Investment Conference 9/8/2014
Nuvo Research Inc. (NRI.TO) To Present At Rodman & Renshaw 16th Annual Global Investment Conference 9/8/2014
Keryx Biopharmaceuticals (KERX) To Present At The Rodman & Renshaw 16th Annual Global Investment Conference 9/8/2014
Arno Therapeutics To Present At Upcoming Investor Conferences 9/8/2014
Novavax, Inc. (NVAX) Presents Data On RSV F Nanoparticle Vaccine Induced Monoclonal Antibody At ICAAC 9/8/2014
Biocryst Pharmaceuticals (BCRX) Announces RAPIVAB™ Trial Results For The Treatment Of Influenza At The ICAAC 2014 Meeting 9/8/2014
DelMar Pharmaceuticals To Present At The SeeThruEquity Fall Microcap Investor Conference 9/8/2014
See Acsis Pharmaceutical Solutions At LogiPharma And PDA/FDA Joint Regulatory Conference 9/8/2014
OSE Pharma To Present At The Rodman & Renshaw 16th Annual Global Investment Conference 9/8/2014
Recro Pharma (REPH) To Present At The 2014 Aegis Healthcare & Technology Conference 9/8/2014
Stemline Therapeutics, Inc. (STML) To Present At The Aegis Capital 2014 Healthcare & Technology Conference 9/8/2014
Anavex Life Sciences Corp. (AVXL.OB) Supports Alzheimer's Foundation Of America's 3rd Annual Concepts In Care Educational Conference 9/8/2014
Radius (RDUS) To Host Scientific Panel Discussion For Investors On Investigational Drug Abaloparatide At ASBMR 2014 9/8/2014
Advaxis, Inc. To Present At Upcoming Investor Conferences 9/8/2014
Becton, Dickinson and Company (BDX) To Present At The Morgan Stanley Global Healthcare Conference 9/8/2014
Sigma-Aldrich Corporation (SIAL) To Present At The Morgan Stanley Global Healthcare Conference 9/8/2014
Sinovac Biotech Ltd. (SVA) Announces New Presentation Time for Aegis Healthcare & Technology Conference 9/8/2014
Relypsa, Inc. (RLYP) Announces Phase 3 Patiromer Data To Be Presented In Late-Breaking Session At Heart Failure Society Of America 18th Annual Scientific Meeting 9/8/2014
Amgen (AMGN) To Present At The Morgan Stanley Global Healthcare Conference 9/8/2014
Dipexium Pharmaceuticals (DPRX) Presents Updated Locilex® Microbiology Data At 54th ICAAC Conference 9/8/2014
Covance Inc. (CVD) To Present At The Morgan Stanley Global Healthcare Conference 9/8/2014
BioLife Solutions, Inc. (BLFS.OB) To Present At The 16th Annual Rodman & Renshaw Global Investment Conference In New York City And The Aegis Healthcare & Technology Conference In Las Vegas 9/8/2014
Synthetic Biologics, Inc. (SYN) Highlights SYN-005 Data Presented At The 54th ICAAC From Novel Whooping Cough (Pertussis) Program 9/8/2014
BioDelivery Sciences International (BDSI) To Present At The Morgan Stanley Global Healthcare Conference 9/8/2014
Immune Pharmaceuticals, Inc. Presenting At The 16th Annual Rodman & Renshaw Global Investment Conference, September 10, 2014 9/8/2014
Soligenix (SNGX) To Present At The 16th Annual Rodman & Renshaw Global Investment Conference In New York City 9/8/2014
Northwest Biotherapeutics (NWBO) To Present Updates At Rodman & Renshaw 16th Annual Global Investment Conference 9/8/2014
Nabriva Therapeutics Presented Data On Lead Pleuromutilin Antibiotic Lefamulin (BC-3781) At The 54th Interscience Conference On Antimicrobial Agents And Chemotherapy In Washington DC 9/8/2014
Celsion Corporation (CLSN) Announces Highlights From Three Presentations Given At The International Liver Cancer Association 2014 Annual Conference 9/8/2014
Clovis Oncology (CLVS) To Present At The 2014 Morgan Stanley Global Healthcare Conference 9/8/2014
BioBlast Pharma (ORPN) To Ring The NASDAQ Stock Market Opening Bell 9/8/2014
La Jolla Pharmaceutical Company (LJPC) To Provide Corporate Overview At The Rodman & Renshaw 16th Annual Global Investment Conference 9/8/2014
Novavax, Inc. (NVAX) Release: ICAAC Presentation: Immunization Of Pregnant Baboons With The RSV F Nanoparticle Vaccine Protects Infant Baboons Challenged With Respiratory Syncytial Virus In A Comparable Manner To Infants Prophylaxed With Palivizumab 9/8/2014
Biotechnology Industry Organization (BIO) Latin America Conference Connects International Industry Leaders 9/8/2014
Vertex Pharmaceuticals (MA) (VRTX) Announces Upcoming Presentations Of Data At North American Cystic Fibrosis Conference - October 9 To 11, 2014 9/8/2014
Endo Pharmaceuticals (ENDP) To Present At Morgan Stanley Global Healthcare Conference 2014 9/8/2014
PharmAthene, Inc. (PIP) To Present At Rodman & Renshaw And Aegis Capital Corporation 2014 Investment Conferences 9/8/2014
Charles River Laboratories (Massachusetts) To Present At Morgan Stanley (MST) Global Healthcare Conference 9/8/2014
MYOS (MYOS) To Present At Rodman & Renshaw 16th Annual Global Investment Conference On September 10, 2014 9/8/2014
Corbus Pharmaceuticals, Inc. To Present At Two Investor Conferences In September 9/8/2014
Boston Therapeutics, Inc. To Present At Rodman & Renshaw Annual Global Investment Conference On September 10, 2014 9/8/2014
Cellceutix (CTIX) To Present At Rodman & Renshaw's 16th Annual Global Investment Conference 9/8/2014
Insmed Incorporated (INSM) To Present At The Rodman & Renshaw Annual Global Investment Conference 9/8/2014
Genticel To Participate In The Rodman & Renshaw Investor Conference In New York – From September 8 To 10 9/8/2014
RedHill Biopharma Ltd. (RDHL) To Present At The Rodman & Renshaw 16th Annual Global Investment Conference 9/5/2014
StemCells Inc. (STEM) To Participate At The 16th Annual Rodman & Renshaw Global Investment Conference 9/5/2014
Cortex Pharmaceuticals, Inc. (COR) To Present At Rodman & Renshaw 16th Annual Global Investment Conference 9/5/2014
Lion Biotechnologies, Inc. To Present At The Rodman & Renshaw 16th Annual Global Investment Conference 9/5/2014
Aldeyra Therapeutics (ALDX) To Present At Upcoming Investor Conference 9/5/2014
Biota Pharmaceuticals, Inc. (BOTA) To Present Preclinical Data On RSV Compound BTA-C585 At ICAAC Meeting 9/5/2014
Alcobra (ADHD) To Present At The Aegis Healthcare & Technology Conference 9/5/2014
Cellectar Biosciences  (NVLT) Announces Participation In Two Upcoming Investor Conferences In September 9/5/2014
Vectura Group plc (VEC.L) Release: Presentation At ERS 9/5/2014
Bio-Rad Laboratories, Inc. (BIO) Customers Present Seminars On Quantitative Western Blotting Using Stain-Free Technology 9/5/2014
Bioo Scientific Corporation Features Sensitive Food Safety Solutions For Aflatoxin M1 Analysis At AOAC 2014 9/5/2014
Mallinckrodt Pharmaceuticals (MNK) Presents 11 Posters With Data On Investigational Opioid, MNK-155, And XARTEMIS™ XR (Oxycodone Hydrochloride And Acetaminophen) Extended Release Tablets (CII) At Painweek 2014 9/5/2014
CytRx Corporation (CYTR) Updates Presentation Time At Aegis 2014 Healthcare & Technology Conference 9/5/2014
Transgenomic, Inc. (TBIO) To Present At Rodman & Renshaw16th Annual Global Investment Conference 9/5/2014
NovaBay Pharmaceuticals, Inc. (NBY) To Present At Rodman & Renshaw16th Annual Healthcare Conference 9/5/2014
Agere Pharmaceuticals CEO To Present Innovations In Formulating For Oral Bioavailability 9/5/2014
Protalex, Inc. (PRTX) To Present At Rodman & Renshaw Annual Global Investment Conference 9/5/2014
Organovo To Present At The Morgan Stanley (MST) Global Healthcare Conference 9/5/2014
Sorrento Therapeutics, Inc. To Present At Two Healthcare Conferences 9/5/2014
AbbVie (ABBV) To Present At Morgan Stanley (MST) Global Healthcare Conference 9/5/2014
Oramed Pharmaceuticals Inc. (ORMP) To Present At Upcoming Conferences 9/5/2014
NeuralStem Inc. President And CEO To Present At The 2014 Rodman & Renshaw Annual Global Investment Conference 9/5/2014
Astellas Pharma Inc. (ALPMY) To Showcase Isavuconazole Data At ICAAC 9/5/2014
CytoSorbents, Inc. To Present At The 2014 Rodman & Renshaw Annual Global Investment Conference 9/5/2014
Pivotal Therapeutics Inc. Release: Unique Vasoprotective And Antihypertensive Effects Of VASCAZEN®'s Formulation Presented At European Society of Cardiology Congress 2014 9/5/2014
Aratana Therapeutics (PETX) To Present At Morgan Stanley (MST) Global Healthcare Conference 9/5/2014
China Biologic Products To Participate In Upcoming Investor Conferences 9/5/2014
Transition Therapeutics Inc. (TTH.TO) To Present At The 16th Annual Rodman & Renshaw Global Investment Conference 9/5/2014
Ruthigen To Present At Rodman & Renshaw 16th Annual Global Investment Conference In New York City 9/5/2014
Insmed Incorporated (INSM) Announces Multiple Clinical And Scientific Presentations At European Respiratory Society's International Congress 2014 9/5/2014
Five Prime Therapeutics, Inc. (FPRX) To Present At Morgan Stanley (MST) 2014 Global Healthcare Conference 9/4/2014
Elite Pharmaceuticals, Inc. (ELI) To Present At The 16th Annual Rodman & Renshaw Global Investment Conference In New York City September 8-10th 9/4/2014
Celldex Therapeutics, Inc. (CLDX) Announces Upcoming Presentation At The Morgan Stanley (MST) Healthcare Conference 9/4/2014
Proactive Capital Group Announces Roster Of Clients Presenting At 16th Annual Rodman & Renshaw Global Investment Conference 9/4/2014
Fate Therapeutics (FATE) To Present At Rodman & Renshaw 16th Annual Global Investment Conference 9/4/2014
Aegerion Pharmaceuticals, Inc. (AEGR) To Present At The Morgan Stanley (MST) Global Healthcare Conference 9/4/2014
Novavax, Inc. (NVAX) To Present RSV Vaccine Preclinical Results At ICAAC 9/4/2014
Biocryst Pharmaceuticals (BCRX) Participates In World Health Organization Consultation On Potential Ebola Therapies 9/4/2014
Pluristem Therapeutics (PSTI) To Present At Financial Conferences In New York City On September 10th And 17th, 2014 9/4/2014
Cesca Therapeutics To Present At The Rodman & Renshaw 16th Annual Global Investment Conference 9/4/2014
Innovus Pharma To Present At The 2014 Aegis Healthcare Conference In Las Vegas, NV And The ee Thru Equity Fall Microcap Investor Conference In New York 9/4/2014
Vical Incorporated (VICL) To Present At The Rodman & Renshaw 16th Annual Global Investment Conference 9/4/2014
Stemline Therapeutics, Inc. (STML) To Present At The Rodman & Renshaw 16th Annual Global Investment Conference 9/4/2014
Sunesis Pharmaceuticals, Inc. (SNSS) To Present At The 2014 Morgan Stanley (MST) Global Healthcare Conference 9/4/2014
Matinas BioPharma To Present At Three Investor Conferences In September 9/4/2014
Two Presentations At International Conferences Of Preclinical Data On NOXXON Pharma AG’s anti-C5a Spiegelmer®, A Potential Drug In Pneumococcal Pneumonia-Induced Sepsis 9/4/2014
Heat Biologics To Present And Webcast At Two Investor Conferences In September 9/4/2014
Protalix Biotherapeutics, Inc. (PLX) To Present At The Rodman & Renshaw 16th Annual Global Investment Conference 9/4/2014
Egalet To Present Data From Abuse-Deterrence Studies At PAINWeek 2014 In Las Vegas 9/4/2014
Evoke Pharma, Inc. To Present At The Aegis Capital Corp. 2014 Healthcare & Technology Conference 9/4/2014
Melinta Therapeutics (Formerly known as Rib-X Pharmaceuticals, Inc.) Highlighting Delafloxacin And ESKAPE Candidates In Twelve Presentations At 2014 ICAAC Meeting 9/4/2014
Ultragenyx Pharmaceuticals (RARE) To Present At The Morgan Stanley (MST) Global Healthcare Conference 9/4/2014
Amarantus BioSciences, Inc. To Present At Sachs Associates 14th Annual Biotech In Europe Forum For Global Partnering And Investment 9/4/2014
Award-Winning PHT Corporation Scientist Dr. Susan Dallabrida To Present Poster On Epro For Multiple Myeloma At ESMO 2014 Congress 9/4/2014
Rexahn Pharmaceuticals, Inc. (RNN) To Present At The 16th Annual Rodman & Renshaw Global Investment Conference On September 9, 2014 9/4/2014
Cerus Corporation (CERS) To Present At The Morgan Stanley (MST) 2014 Global Health Care Conference On September 10, 2014 9/4/2014
Teva Pharmaceutical Industries Limited (TEVA) To Present At The Morgan Stanley (MST) Global Healthcare Conference 9/4/2014
Acorda Therapeutics (ACOR) To Present At The Aegis Capital 2014 Healthcare And Technology Conference 9/4/2014
Biotechnology Industry Organization (BIO) Issues Call For Sessions For 2015 BIO International Convention 9/4/2014
Anacor Pharmaceuticals, Inc. (ANAC) To Present At Morgan Stanley Global Healthcare Conference 9/4/2014
RestorGenex To Present At Rodman & Renshaw Global Investment Conference 9/4/2014
AmpliPhi Biosciences Corporation (APHB) To Present At Rodman & Renshaw 16th Annual Global Investment Conference 9/4/2014
Gilead Sciences, Inc. (GILD) To Present At Two Upcoming Investor Conferences In September 9/4/2014
Ironwood Pharmaceuticals (IRWD) To Present At Morgan Stanley Global Healthcare Conference 9/4/2014
Alnylam Pharmaceuticals (ALNY) To Webcast Presentation At Morgan Stanley Global Healthcare Conference 9/4/2014
SciClone Pharmaceuticals, Inc. (SCLN) To Present At Aegis 2014 Healthcare & Technology Conference On September 11, 2014 9/4/2014
Titan Pharmaceuticals (TTP) To Present At Rodman & Renshaw 16th Annual Global Investment Conference 9/4/2014
ContraFect Corporation (CFRXU) To Present At Rodman & Renshaw 16th Annual Healthcare Conference 9/4/2014
Marina Biotech, Inc. (MRNA) To Present Rare Disease Clinical Strategy at Upcoming Investor Conferences 9/4/2014
Inovio Pharmaceuticals (INO) To Present At Upcoming Investor Conferences 9/4/2014
Lexicon Pharmaceuticals, Inc. (LXRX) To Present At The Morgan Stanley (MST) 2014 Global Healthcare Conference 9/4/2014
Dr. Jeanne M. Novak, President & CEO Of CBR International Corp.®, To Attend World Health Organization Meeting To Address Leading Experimental Treatments And Vaccines For The Ebola Virus, September 4 - 5, 2014, Geneva, Switzerland 9/4/2014
Relmada Therapeutics To Present At The 16th Annual Rodman & Renshaw Global Investment Conference In New York City September 8-10th, 2014 9/4/2014



//-->